abstract |
The present invention relates to compounds represented by the following formulas (I) and (I-A). Also described are uses for treating inflammatory diseases of chemoattractant receptor-homologous molecules expressed on Th2, the compounds that inhibit G-protein coupled receptors, referred to simply as " CRTH2 ". Variables of formulas (I) and (I-A) are defined herein. |